PROKIDNEY CORP
For the period ended Mar 31, 2024. Filed May 10, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 10, 2024
PROK$1.15+0.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except share data)
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $84,389 | $60,649 |
| Marketable securities | 244,609 | 302,301 |
| Interest receivable | 1,903 | 1,375 |
| Prepaid assets | 3,106 | 3,399 |
| Prepaid clinical | 6,151 | 6,413 |
| Other current assets | — | 9 |
| Total current assets | 340,158 | 374,146 |
| Fixed assets, net | 41,937 | 42,143 |
| Right of use assets, net | 5,668 | 4,263 |
| Total assets | $387,763 | $420,552 |
| Liabilities and Shareholders' Deficit | ||
| Accounts payable | $3,376 | $5,098 |
| Lease liabilities | 1,092 | 803 |
| Accrued expenses and other | 13,263 | 17,665 |
| Income taxes payable | 1,570 | 1,472 |
| Total current liabilities | 19,301 | 25,038 |
| Income tax payable, net of current portion | 568 | 568 |
| Lease liabilities, net of current portion | 4,859 | 3,610 |
| Total liabilities | 24,728 | 29,216 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interest | 1,459,097 | 1,494,732 |
| Shareholders’ deficit | ||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 61,621,330 and 59,880,347 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 6 | 6 |
| Class B ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 167,723,553 and 168,297,916 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 17 | 17 |
| Additional paid-in capital | 53,114 | 36,114 |
| Accumulated other comprehensive (loss) gain | (44) | 130 |
| Accumulated deficit | (1,149,155) | (1,139,663) |
| Total shareholders' deficit | (1,096,062) | (1,103,396) |
| Total liabilities and shareholders' deficit | $387,763 | $420,552 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.